Posts in tag

biologics


The inclusion of the first monoclonal antibody biosimilar on the PBS will deliver immediate savings to the Federal Government; however the full potential of this and other biosimilar medicines relies …

Pfizer today confirmed that the first mAb biosimilar, Inflectra (infliximab), will be added to the PBS on 1 December 2015 for the treatment of eight inflammatory conditions.

The Department of Health is seeking feedback on the Implementation Framework for the Biosimilars Awareness project. The Department of Health says the aim of the project is improve awareness and …

The High Court decision to disallow patenting of isolated genetic materials is a worry for the innovative medicines sector, says Medicines Australia. “It is essential that Australia maintains strong and …

The outcomes of the negotiations for the Trans-Pacific Partnership agreed to in Atlanta overnight are a disappointing outcome and a missed opportunity to stimulate and grow the Australian biopharmaceutical industry, …

The conclusion of the Trans Pacific Partnership was announced last night with some welcome news for Australian health advocates, but major concerns remain, says the Public Health Association of Australia. …

The PSA has released its position statement on biologics, stating that it believes a consensus Australian document on terminology and definitions relating to biological medicines, including biosimilar medicines, should be …

The first in a new class of biologic medicine that acts to interrupt the inflammatory cycle and help clear the skin of patients with moderate-to-severe psoriasis has been added to the PBS from September 1, 2015.

The Generic and Biosimilar Medicines Association has welcomes the recommendation by the PBAC to list biosimilar infliximab (Inflectra) on the PBS and to recommend the marking as equivalent, also known …

Medicines Australia has expressed concern about the PBAC’s recommendation that pharmacists be allowed to substitute the biosimilars in place of biologic medicines prescribed by a patient’s doctor. “The so-called ‘a-flagging’ …

The Generic and Biosimilar Medicines Association has welcomed the approval of biosimilar infliximab, Inflectra. Inflectra is the first biosimilar infliximab to be approved in Australia, providing an alternative, affordable treatment …

As trade ministers meet in Hawaii on 28-31 July in an effort to finalise the Trans Pacific Partnership, the Public Health Association of Australia and other stakeholders say that lives …